| Hans Peter Roethling, MD | |
|
102 Handley Park Court, Goldsboro, NC 27534-1769 | |
| (919) 734-3344 | |
| (919) 735-3025 |
| Full Name | Hans Peter Roethling |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 102 Handley Park Court, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629059704 | NPI | - | NPPES |
| 8972811 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 96000707 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Illinois Ob-gyn Associates Sc | 2961478185 | 7 |
News Archive
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.
A collaborative team from Bournemouth University, led by nutrition expert Professor Heather Hartwell, are hoping to change our eating habits, championing vegetable consumption through a Europe-wide research project called VeggiEAT.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
› Verified 1 days ago
| Entity Name | Shawnee Health Service And Development Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639295314 PECOS PAC ID: 1658285671 Enrollment ID: O20031120000454 |
News Archive
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.
A collaborative team from Bournemouth University, led by nutrition expert Professor Heather Hartwell, are hoping to change our eating habits, championing vegetable consumption through a Europe-wide research project called VeggiEAT.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
› Verified 1 days ago
| Entity Name | Southern Illinois Ob-gyn Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699838276 PECOS PAC ID: 2961478185 Enrollment ID: O20040908001144 |
News Archive
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.
A collaborative team from Bournemouth University, led by nutrition expert Professor Heather Hartwell, are hoping to change our eating habits, championing vegetable consumption through a Europe-wide research project called VeggiEAT.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hans Peter Roethling, MD 102 Handley Park Court, Goldsboro, NC 27534-1769 Ph: (919) 734-3344 | Hans Peter Roethling, MD 102 Handley Park Court, Goldsboro, NC 27534-1769 Ph: (919) 734-3344 |
News Archive
Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.
A collaborative team from Bournemouth University, led by nutrition expert Professor Heather Hartwell, are hoping to change our eating habits, championing vegetable consumption through a Europe-wide research project called VeggiEAT.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.
Naturxan, LLC, a joint venture between Archer Daniels Midland Company and Igene Biotechnology, Inc., today announced that it has completed an expansion of its production and distribution capabilities to provide worldwide availability of Aquasta, a naturally sourced astaxanthin made from Phaffia yeast for enriching and pigmenting salmon and trout consuming aquaculture feeds.
› Verified 1 days ago
Charles Michael Brooks, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 102 Handley Park Court, Goldsboro, NC 27534 Phone: 919-734-3344 Fax: 919-735-3025 | |
Lori Diane Spisak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 102 Handley Park Ct, Goldsboro, NC 27534 Phone: 919-734-3344 Fax: 919-735-3025 | |
Dr. Glen A Nowachek, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2608 Hospital Rd, Goldsboro, NC 27534 Phone: 919-735-3464 Fax: 919-735-0080 | |
Dr. Lauren M Watty, DO, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 102 Handley Park Ct, Goldsboro, NC 27534 Phone: 919-734-3344 Fax: 919-735-3025 | |
Dr. Gregory S Nichols, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2608 Hospital Rd, Goldsboro, NC 27534 Phone: 919-735-3464 Fax: 919-735-0080 | |
Dr. Joseph P Flynn, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2608 Hospital Rd, Goldsboro, NC 27534 Phone: 919-735-3464 Fax: 919-735-0080 |